{"id":"cls006","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"CLS006 is an investigational dermatological compound in Phase 3 development by Maruho Co., Ltd., a Japanese pharmaceutical company specializing in dermatology. The specific molecular mechanism remains proprietary and not widely disclosed in public literature. Given Maruho's therapeutic focus, it is likely designed to address inflammatory skin diseases or other dermatological conditions through a topical formulation.","oneSentence":"CLS006 is a topical agent developed for dermatological conditions, likely targeting inflammatory or proliferative skin pathways.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:06:28.100Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Investigational dermatological indication (specific indication not publicly disclosed)"}]},"trialDetails":[{"nctId":"NCT03259620","phase":"PHASE3","title":"A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts","status":"COMPLETED","sponsor":"Maruho Co., Ltd.","startDate":"2017-10-30","conditions":"Cutaneous Common Warts","enrollment":491},{"nctId":"NCT02971891","phase":"PHASE3","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts","status":"COMPLETED","sponsor":"Maruho Co., Ltd.","startDate":"2017-01","conditions":"Cutaneous Common Warts","enrollment":484}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"CLS006","genericName":"CLS006","companyName":"Maruho Co., Ltd.","companyId":"maruho-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CLS006 is a topical agent developed for dermatological conditions, likely targeting inflammatory or proliferative skin pathways. Used for Investigational dermatological indication (specific indication not publicly disclosed).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}